Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysisMarco Valgimigli, Giovanni Pedrazzini, Farzin Beygui et al.|European Heart Journal|2022Cited by 78